Cargando…

Effects of bone marrow-derived cells on monocrotaline- and hypoxia-induced pulmonary hypertension in mice

BACKGROUND: Bone marrow -derived cells (BMDCs) can either limit or contribute to the process of pulmonary vascular remodeling. Whether the difference in their effects depends on the mechanism of pulmonary hypertension (PH) remains unknown. OBJECTIVES: We investigated the effect of BMDCs on PH induce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raoul, William, Wagner-Ballon, Orianne, Saber, Guitanouch, Hulin, Anne, Marcos, Elisabeth, Giraudier, Stéphane, Vainchenker, William, Adnot, Serge, Eddahibi, Saadia, Maitre, Bernard
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1797016/ https://www.ncbi.nlm.nih.gov/pubmed/17263874 http://dx.doi.org/10.1186/1465-9921-8-8

Ejemplares similares

Impact of interleukin-6 on hypoxia-induced pulmonary hypertension and lung inflammation in mice
por: Savale, Laurent, et al.
Publicado: (2009)

Anorexigen-induced pulmonary hypertension and the serotonin (5-HT) hypothesis: lessons for the future in pathogenesis
por: Eddahibi, Saadia, et al.
Publicado: (2002)

Gene expression in lungs of mice lacking the 5-hydroxytryptamine transporter gene
por: Crona, Daniel, et al.
Publicado: (2009)

The Beneficial Effect of Suramin on Monocrotaline-Induced Pulmonary Hypertension in Rats
por: Izikki, Mohamed, et al.
Publicado: (2013)

Pulmonary hemodynamic responses to inhaled NO in chronic heart failure depend on PDE5 G(-1142)T polymorphism
por: Damy, Thibaud, et al.
Publicado: (2011)

CCND2 mutations are infrequent events in BCR-ABL1 negative myeloproliferative neoplasm patients
por: Cassinat, Bruno, et al.
Publicado: (2020)

Influence of gender in monocrotaline and chronic hypoxia induced pulmonary hypertension in obese rats and mice
por: Neupane, Balram, et al.
Publicado: (2020)

A Senescence-Like Cell-Cycle Arrest Occurs During Megakaryocytic Maturation: Implications for Physiological and Pathological Megakaryocytic Proliferation
por: Besancenot, Rodolphe, et al.
Publicado: (2010)

Silibinin efficacy in a rat model of pulmonary arterial hypertension using monocrotaline and chronic hypoxia
por: Zhang, Tingting, et al.
Publicado: (2019)

Right Ventricle Remodeling Metabolic Signature in Experimental Pulmonary Hypertension Models of Chronic Hypoxia and Monocrotaline Exposure
por: Hautbergue, Thaïs, et al.
Publicado: (2021)

Changes of Gene Expression after Bone Marrow Cell Transfusion in Rats with Monocrotaline-Induced Pulmonary Hypertension
por: Kim, Kwan Chang, et al.
Publicado: (2012)

Bone Marrow Endothelial Progenitor Cells Are the Cellular Mediators of Pulmonary Hypertension in the Murine Monocrotaline Injury Model
por: Aliotta, Jason M., et al.
Publicado: (2017)

Chronic hypoxia aggravates monocrotaline-induced pulmonary arterial hypertension: a rodent relevant model to the human severe form of the disease
por: Coste, Florence, et al.
Publicado: (2017)

Therapeutic Efficacy of Valproic Acid in a Combined Monocrotaline and Chronic Hypoxia Rat Model of Severe Pulmonary Hypertension
por: Lan, Beidi, et al.
Publicado: (2015)

Pipersentan: A De Novo Synthetic Endothelin Receptor Antagonist that Inhibits Monocrotaline- and Hypoxia-Induced Pulmonary Hypertension
por: Zhang, Zeyu, et al.
Publicado: (2022)

The STATus of STAT3 in Lung Cell Senescence?
por: Adnot, Serge, et al.
Publicado: (2019)

Intratracheal Administration of Prostacyclin Analogue–incorporated Nanoparticles Ameliorates the Development of Monocrotaline and Sugen-Hypoxia-induced Pulmonary Arterial Hypertension
por: Akagi, Satoshi, et al.
Publicado: (2016)

Interleukin-6 displays lung anti-inflammatory properties and exerts protective hemodynamic effects in a double-hit murine acute lung injury
por: Voiriot, Guillaume, et al.
Publicado: (2017)

Monocrotaline: Histological Damage and Oxidant Activity in Brain Areas of Mice
por: Honório Junior, José Eduardo Ribeiro, et al.
Publicado: (2012)

Beclin1 circulating levels and accelerated aging markers in COPD
por: Schlemmer, Frédéric, et al.
Publicado: (2018)

Macrophage migration inhibitory factor is overproduced through EGR1 in TET2(low) resting monocytes
por: Pronier, Elodie, et al.
Publicado: (2022)

Telomere shortening during human septic shock: influence of sepsis mediators, role in organ failures, and septic myocardial dysfunction
por: Razazi, Keyvan, et al.
Publicado: (2021)

Pathological Changes in Rats as a Result of Treatment with Monocrotaline
por: Schoental, R., et al.
Publicado: (1955)

Lodenafil treatment in the monocrotaline model of pulmonary hypertension in rats
por: Polonio, Igor Bastos, et al.
Publicado: (2014)

Arginase Inhibition Reverses Monocrotaline-Induced Pulmonary Hypertension
por: Jung, Christian, et al.
Publicado: (2017)

Effects of renal denervation on monocrotaline induced pulmonary remodeling
por: Liu, Qian, et al.
Publicado: (2017)

Cannabidiol Ameliorates Monocrotaline-Induced Pulmonary Hypertension in Rats
por: Sadowska, Olga, et al.
Publicado: (2020)

Identification of Lymphomyeloid Primitive Progenitor Cells in Fresh Human Cord Blood and in the Marrow of Nonobese Diabetic–Severe Combined Immunodeficient (NOD-SCID) Mice Transplanted with Human CD34(+) Cord Blood Cells
por: Robin, Catherine, et al.
Publicado: (1999)

High expression of CXCR4 and stem cell markers in a monocrotaline and chronic hypoxia-induced rat model of pulmonary arterial hypertension
por: Zhang, Tingting, et al.
Publicado: (2018)

Are Systemic Manifestations Ascribable to COPD in Smokers? A Structural Equation Modeling Approach
por: Boyer, Laurent, et al.
Publicado: (2018)

Involvement of mast cells in monocrotaline-induced pulmonary hypertension in rats
por: Dahal, Bhola K, et al.
Publicado: (2011)

Simvastatin, Sildenafil and Their Combination in Monocrotaline Induced Pulmonary Arterial Hypertension
por: Lee, Dong Seok, et al.
Publicado: (2010)

Therapeutic efficacy of TBC3711 in monocrotaline-induced pulmonary hypertension
por: Kosanovic, Djuro, et al.
Publicado: (2011)

Quercetin attenuates the progression of monocrotaline-induced pulmonary hypertension in rats
por: Gao, Hanhua, et al.
Publicado: (2012)

Maprotiline Prevents Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats
por: Tong, Yi, et al.
Publicado: (2018)

Magnesium Sulfate Mitigates the Progression of Monocrotaline Pulmonary Hypertension in Rats
por: Chang, Chao-Yuan, et al.
Publicado: (2019)

Arctigenin prevents monocrotaline-induced pulmonary arterial hypertension in rats
por: Jiang, Wei-Long, et al.
Publicado: (2019)

Dapagliflozin, sildenafil and their combination in monocrotaline-induced pulmonary arterial hypertension
por: Tang, Yi, et al.
Publicado: (2022)

Notopterol Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rat
por: Huang, Lin, et al.
Publicado: (2022)

Monocrotaline Toxicity Alters the Function of Hepatocyte Membrane Transporters in Rats
por: Pastor, Catherine M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_aps4vuui1lqpr02of89p27e1at